<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00735488</url>
  </required_header>
  <id_info>
    <org_study_id>0011-08-EMC</org_study_id>
    <nct_id>NCT00735488</nct_id>
  </id_info>
  <brief_title>Sickle Cell Anemia Screening and Prevention in Northern Israel</brief_title>
  <official_title>Summary of the Data From the Prevention Programme for Hemoglobinopathies in Northern Israel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Israel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since 1987, a screening for Î² Thalassemia in pregnant women is carried on in northern Israel,
      and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and
      others.

      In this study, the investigators intend to summarize the results of this preventive program
      aiming to detect couples at risk for having offspring with Thalassemia or SCA, the compliance
      regard to genetic counseling and prenatal diagnosis and the incidence of new affected babies
      born.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of carriers detected</measure>
    <time_frame>End of study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Couples referred for prenatal diagnosis</measure>
    <time_frame>End of study</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">69</enrollment>
  <condition>Thalassemia</condition>
  <condition>Sickle Cell Anemia</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Thalassemia Minor carriers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <description>Sickle cell carriers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Summary of data</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The program for prevention of hemoglobinopathies in Northern Israel, instituted since 1987,
        covered the northern part of Israel, including the Jezreel valley, the Nazareth area, the
        upper Galilee, the Hula valley and the northern part of the seashore region7. The overall
        population in this region is about a million inhabitants with about 50 % of Arab
        population, and a significant percentage of them from Bedouin origin, a population that at
        least partially is of African origin.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: All pregnant women tested and their husband in those cases that the
        woman test revealed abnormal hemoglobin.

        Exclusion Criteria: No exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Koren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Hematology Unit - Ha'Emek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2008</study_first_submitted>
  <study_first_submitted_qc>August 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2008</study_first_posted>
  <last_update_submitted>August 30, 2015</last_update_submitted>
  <last_update_submitted_qc>August 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Dr Koren Ariel</investigator_full_name>
    <investigator_title>Head of Pediatric Hematology Unit and Pediatric Dpt B</investigator_title>
  </responsible_party>
  <keyword>Thalassemia</keyword>
  <keyword>Sickle cell anemia</keyword>
  <keyword>Carrier detection</keyword>
  <keyword>Prenatal Diagnosis</keyword>
  <keyword>Genetic counseling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

